BioWorld Asia

Jan. 9, 2002

View Archived Issues

PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback

New Heart Drugs Could Be Hiding In A Glass Of Vin Rouge

NeuTec Raising 10M To Fund Programs Targeting Infections

Budget Cuts Sidetrack Plan For Israeli Biotech Institute

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Novartis Enlists Optimata To Analyze New Drug Candidates

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

ExonHit Partners With IDEC To Develop Antibody Therapeutics

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma. Read More

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...